Gella, Ramil S.

HRN: 25-74-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/25/2024
08/30/2024
PO
500
OD
Lower Respiratory Tract Infection
Waiting Final Action 
08/26/2024
CEFTAZIDIME 1GM (VIAL)
08/26/2024
09/02/2024
IV
1g
Q8hr
CAP-MR
Waiting Final Action 
08/26/2024
CEFTRIAXONE 1G (VIAL)
08/26/2024
09/01/2024
IV
2grams
Q12
T/C Bacterial Meningitis
Waiting Final Action 
08/31/2024
CEFTRIAXONE 1G (VIAL)
09/01/2024
09/07/2024
IV
2g
Once Daily
CAPMR
Waiting Final Action 
09/01/2024
CEFTAZIDIME 1GM (VIAL)
09/01/2024
09/07/2024
IV
2g
Q8h
BA In AE; T/c PTB Relapse
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: